# A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy

> **NCT01093157** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 10 (actual)

## Conditions studied

- Glomerulonephritis

## Interventions

- **DRUG:** Adrenocorticotrophic hormone ACTH

## Key facts

- **NCT ID:** NCT01093157
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2013-01
- **Final completion:** 2013-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093157, "A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01093157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*